EUVIMEDEUVIMED entdecken
Crossref

Valproic acid effects on human adipose-derived stem cell differentiation into oligodendrocytes and improved remyelination in a mouse model of Multiple Sclerosis

Sahar Ghosouri, Mohammad Bakhtiari, Soleimani Mitra, Nazem Ghasemi

The International Journal of Developmental Biology · 2023

DOI: 10.1387/ijdb.230154ng ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Developmental Biology, 2023. Verfasst von Sahar Ghosouri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Multiple Sclerosis, Remyelination. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valproic acid (VPA), a neuroprotective agent and inhibitor of GSK3-β, along with human Adipose-Derived Stem Cells (hADSCs) have been proposed to be potential therapeutic agents for neurodegenerative disorders. In the present study, we have assessed the effects of VPA alone or in combination with hADSCs on oligodendrocyte differentiation, remyelination, and functional recovery in a mouse model of Multiple Sclerosis (MS). These MS-model mice were randomly divided into cuprizone, sham, VPA, hADSC, and VPA/hADSC groups, with 10 mice considered a control group (healthy mice). The hanging wire test was used to measure motor behavior. To estimate the level of myelination, we performed toluidine blue staining and immunofluorescent staining for OLIG2 and MOG-positive cells. Real-time PCR was used to evaluate the expression of β-catenin, human and mouse Mbp, Mog, and Olig2 genes. Remyelination and motor function improved in mice receiving VPA, hADSCs, and especially VPA/hADSCs compared to the Cup and Sham groups ( P < 0.01 ). Additionally, the number of MOG and OLIG2 positive cells significantly increased in the VPA/hADSCs group compared to the Cup and Sham groups ( P < 0.01 ). The expression of β-catenin, myelin and the other oligodendrocyte-specific genes was significantly higher in the VPA recipient groups. Valproic acid can enhance the differentiation of stem cells into oligodendrocytes, making it a potential candidate for MS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisRemyelinationHumansMiceAnimalsValproic Acidbeta CateninGlycogen Synthase Kinase 3Cell DifferentiationOligodendrogliaMice, Inbred C57BLDisease Models, Animal

Substanzen

Valproic Acidbeta CateninGlycogen Synthase Kinase 3

Autor:innen und Institutionen

  • Department of Anatomical Sciences, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Behbahan Faculty of Medical Sciences, Behbahan, Iran.

Zitieren

APA

Ghosouri, S., Bakhtiari, M., Mitra, S., & Ghasemi, N. (2023). Valproic acid effects on human adipose-derived stem cell differentiation into oligodendrocytes and improved remyelination in a mouse model of Multiple Sclerosis. The International Journal of Developmental Biology. https://doi.org/10.1387/ijdb.230154ng

Vancouver

Ghosouri S, Bakhtiari M, Mitra S, Ghasemi N. Valproic acid effects on human adipose-derived stem cell differentiation into oligodendrocytes and improved remyelination in a mouse model of Multiple Sclerosis. The International Journal of Developmental Biology. 2023. doi:10.1387/ijdb.230154ng

BibTeX
@article{Ghosouri2023,
  author = {Ghosouri, Sahar and Bakhtiari, Mohammad and Mitra, Soleimani and Ghasemi, Nazem},
  title = {Valproic acid effects on human adipose-derived stem cell differentiation into oligodendrocytes and improved remyelination in a mouse model of Multiple Sclerosis},
  journal = {The International Journal of Developmental Biology},
  year = {2023},
  doi = {10.1387/ijdb.230154ng}
}
Kostenlos starten →